
Hypherdata is a global healthcare network facilitating the exchange of real-world data (RWD) for Real World Evidence (RWE) studies. Their platform acts as a reverse data auction where healthcare organizations, research institutions, and health tech companies can submit competitive bids to provide data sets requested by pharmaceutical companies or other startups. Hypherdata aims to accelerate AI and precision medicine by providing access to RWD from vetted health institutions at a more affordable cost and in a fraction of the traditional time. They offer streamlined procurement processes, standardized contracting, and secure data exchange vaults. The company boasts a network of over 500 innovative companies and 400+ vetted medical data providers across multiple continents, covering 32 medical areas. Their business model is centered around facilitating these data transactions, with revenue likely generated from platform fees or commissions on data licenses.

Hypherdata is a global healthcare network facilitating the exchange of real-world data (RWD) for Real World Evidence (RWE) studies. Their platform acts as a reverse data auction where healthcare organizations, research institutions, and health tech companies can submit competitive bids to provide data sets requested by pharmaceutical companies or other startups. Hypherdata aims to accelerate AI and precision medicine by providing access to RWD from vetted health institutions at a more affordable cost and in a fraction of the traditional time. They offer streamlined procurement processes, standardized contracting, and secure data exchange vaults. The company boasts a network of over 500 innovative companies and 400+ vetted medical data providers across multiple continents, covering 32 medical areas. Their business model is centered around facilitating these data transactions, with revenue likely generated from platform fees or commissions on data licenses.
What they do: B2B closed data marketplace and synthetic-data services for life sciences (RWD/RWE, AI/ML)
Headquarters: Amsterdam, Netherlands
Founding / launch: 2019 (launch Sep 2019 reported)
Team size (reported): Approximately 2–10 employees
Latest funding: Seed (Aug 27, 2024)
Real-world data access and procurement for life-sciences research, RWE studies, and AI model development.
2019
Life sciences / Health data marketplace
€850000
Dealroom lists an Aug 2024 Seed round of €850k with investors Nation 1 and CB ESPRi. Crunchbase reports a Seed round on Aug 27, 2024.